Alyssa George on Clinical and Economic Impact of a Eptacog Beta
Alyssa George, Clinical Pharmacist at Henry Ford Health, shared on LinkedIn:
”I am excited to share that my medication use evaluation looking at the use of recombinant factor VIIa has been published in Clinical and Applied Thrombosis and Hemostasis!
For the last two years, we have been working on putting together this manuscript to report our clinical experiences and economical savings with a recombinant factor VIIa formulary interchange from eptacog alfa to eptacog beta.
We successfully used eptacog beta for several labeled and off-label indications, including bleeding and peri-operative management for those with acquired or congenital hemophilia A/B, delta granule storage pool disorder, and intra-operative coagulopathy during cardiac surgery.
We found no incidence of thrombotic events and a low rate of bleeding complications.
For those interested, the article is linked below.
I would like to thank my preceptors Katelyn Sylvester and Dareen Kanaan for all of their hard work on helping me get this manuscript published!”
Read the full article here.
Article: Real World Experience with use of Coagulation Factor VIIa at an Academic Medical Center
Authors: Alyssa George, Katelyn Sylvester, Dareen Kanaan, Prabashni Reddy, John Fanikos, Jean Connors, Nathan Connell
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin